Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/07 → 8/31/08 |
Funding
- University of Illinois at Chicago (NU UIC06CC12)
- Merck & Co., Inc. (NU UIC06CC12)
Prot# NU UIC06CC12: An Open Label Phase II Study of Aprepitant for Multi-Day Moderately-High to Highly Emetogenic Chemotherapy Regimens
- Agulnik, Mark (PD/PI)
Project: Research project